Liver Cancer: Redefining the tumor burden of metaphase hepatocellular carcinoma: 7-11 criteria

Hepatocellular carcinoma (HCC) is one of the common malignant tumors

Hepatocellular carcinoma (HCC) is one of the common malignant tumors

The study included 632 patients with mid-term HCC treated with first-line TACE from 2007 to 2019

The study included 632 patients with mid-term HCC treated with first-line TACE from 2007 to 2019

Among the 632 patients included, based on the criteria of up-to-7, up-to-11, 5-7, and 7 lesions, 70.

Different standard curative effect ratio

Multivariate analysis of related factors in patients with imaging response found that AFP>200 ng/mL (OR) = 0.

Multivariate analysis of related factors in patients with imaging response found that AFP>200 ng/mL (OR) = 0.

Based on the 7-11 criteria, the median RFS of patients with low, moderate, and high tumor burden were 15.

7-11 standard RFS and OS

Multivariate analysis found that age> 60 years (HR = 1.

Multivariate analysis found that age> 60 years (HR = 1.

Predictors of OS

In summary, studies have shown that for TACE-treated HCC patients in the mid-term, the new 7-11 standard better predicts the efficacy and prognosis

In summary, studies have shown that for TACE-treated HCC patients in the mid-term, the new 7-11 standard better predicts the efficacy and prognosis

Original source:

Ya-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al.

Ya-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al.
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria.
Liver Cancer.
DOI: 10.
1159/000517393.
Published online: July 22 , 2021.


Leave a message here